These compounds may interact with:
G2/mitotic-specific cyclin-B1
Potentially involved in: cancer; polycystic ovary syndrome; adrenocortical carcinoma; adult high grade glioma; astrocytic glioma; atopic dermatitis; atypical teratoid / rhabdoid tumor; breast cancer; breast carcinoma; colon cancer; ductal carcinoma in situ; endometriosis; glioblastoma; group 3 medulloblastoma; intraductal papillary-mucinous adenoma (ipma); intraductal papillary-mucinous carcinoma (ipmc); intraductal papillary-mucinous neoplasm (ipmn); invasive ductal carcinoma; lung adenocarcinoma; lung cancer
Disease data sourced from Pharos.